LD-2 disclosure · 2nd Quarter - Report
DISCOVERY LABORATORIES
Client
- Description
- Biodefense & Civilian Drug Development
- Location
- Pennsylvania · United States of America
Registrant
- Description
- Business Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesDefense
Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.
Lobbyistsmr DONALD DALRYMPLE
Covered position (mr DONALD DALRYMPLE): Principal
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Army, Dept of (Other) · Health & Human Services, Dept of (HHS) · Ballistic Missile Defense Organization · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Natl Institutes of Health (NIH) · Homeland Security, Dept of (DHS) · Defense Threat Reduction Agency (DTRA)
Homeland Security
Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.
Lobbyistsmr DONALD DALRYMPLE
Covered position (mr DONALD DALRYMPLE): Principal
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Defense, Dept of (DOD) · Army, Dept of (Other) · Health & Human Services, Dept of (HHS) · Ballistic Missile Defense Organization · Centers For Disease Control & Prevention (CDC) · Food & Drug Administration (FDA) · Natl Institutes of Health (NIH) · Homeland Security, Dept of (DHS) · Defense Threat Reduction Agency (DTRA)